Methylation Stack

Best-in-class: Methylation Bundle

Thorne's methylation bundle: separate products boxed together to cover the active B vitamins and methyl donors a methylation protocol runs on. The individual products and their amounts are Thorne's to set and have not been read off a filed panel.

How Methylation Stack actually works

Methylfolate, methylcobalamin, P5P and betaine — the four inputs the one-carbon cycle needs to regenerate SAMe, the universal methyl donor. SAMe drives DNA methylation, monoamine synthesis and phase-II detoxification, so a bottleneck here has unusually broad downstream consequences.

Where to get Methylation Stack

The evidence for Methylation Stack

Graded by what exists behind each claim.

✅ Clinically validated

• Active B-vitamin/methyl-donor combinations reliably lower elevated homocysteine (well-established) and support methylation-dependent processes.

📊 Correlative data

• A bundle has no epidemiology of its own. Where observational evidence exists it belongs to the individual ingredients and sits on their pages — read it there rather than inferring it for the combination, which nobody has studied as a unit.

🧪 Theoretical / extrapolated benefits

• No bundle has been studied as a unit, so any claim about the combination is extrapolated from the individual components. Where two ingredients share a pathway, additivity is plausible; where they do not, expect independence. Read each component's own page for what is actually predicted of it.

How to read these tiers: they say how much human evidence exists, not how well something works — and ✗ flags harm, never a disappointing trial. How the evidence tiers work →

What Methylation Stack actually does

Homocysteine is not a pathway. It is a junction with three exits, and this bundle puts an ingredient at each of them — which is the only bundle in the Stacks category where the parts have a real mechanistic reason to be sold together.

Exit one: remethylation by methionine synthase, and this is the step where two ingredients meet. Methionine synthase takes a methyl group off 5-methyltetrahydrofolate and puts it onto homocysteine, regenerating methionine. Folate is the substrate. Methylcobalamin, sitting in the enzyme's cob(I) center, is the cofactor that carries the methyl group across. Both are in the box, and they are not two nutrients acting in parallel — they are two halves of one catalytic cycle, and supplying either one alone leaves the other rate-limiting. That is what a bundle is supposed to mean and it is almost never true.

Exit two: the betaine branch, which runs beside it and not through it. Betaine-homocysteine methyltransferase does the same chemistry with a different donor: betaine gives up a methyl group, becomes dimethylglycine, and homocysteine becomes methionine with no folate and no B12 involved at all. The catch is anatomical — BHMT is expressed essentially in liver and kidney, so the betaine arm is a hepatic override, not a systemic one. When somebody says a methylation stack has redundancy built in, this is the redundancy, and it only covers two organs.

Exit three: transsulfuration, which is B6's job and points the other way. Cystathionine beta-synthase condenses homocysteine with serine, and cystathionine gamma-lyase then releases cysteine — the rate-limiting precursor for glutathione. Both enzymes use pyridoxal-5-phosphate. So the B6 in this box is not helping recycle homocysteine; it is helping destroy it, permanently, down a drain that ends in glutathione. Folate and B12 push the junction one way, B6 pushes it the other, and both lower the number you measure. No page in this market states that its two arms work in opposite directions.

The switch that decides which exit is used. S-adenosylmethionine allosterically inhibits MTHFR and activates CBS. When methyl groups are plentiful the cell stops making more 5-methyl-THF and opens the transsulfuration drain instead. This is why loading methyl donors into someone whose methylation is already adequate does not push the system harder — the regulation was designed to prevent exactly that.

And the reason the stack exists commercially. The MTHFR C677T variant makes the enzyme thermolabile, so the TT homozygote converts less 5,10-methylene-THF into the 5-methyl form that methionine synthase requires, and runs a higher homocysteine Frosst 1995. Giving 5-MTHF supplies the product of the defective step directly. That is a coherent argument and it is specific to one genotype.

Cell, rodent, human — and where it stops

Folate and B12, in humans, at scale, with the disappointment attached. Eight randomized trials, 37,485 individuals: B vitamins lowered homocysteine and did not reduce cardiovascular disease, cancer or cause-specific mortality Clarke 2010. Read the two halves in order, because the order is the whole point. The biochemical claim held — give these vitamins and the number falls, reliably, in tens of thousands of people. The clinical claim the number was standing in for did not. Any page that quotes the first half and stops is selling a surrogate.

Betaine, and the first place the arithmetic bites. The randomized evidence that betaine lowers fasting plasma homocysteine in healthy men and women was generated at 6 g per day Steenge 2003. That is six grams — a heaped teaspoon of powder, not an ingredient in a capsule. A methylation blend that lists trimethylglycine among eight actives is carrying it at a few hundred milligrams, which is a tenth to a twentieth of the trial dose. The arithmetic is one subtraction and it decides whether the betaine arm on the label is a mechanism or a garnish. This site cannot do that subtraction for you, because the product record here says only as directed — see the product page for exact contents, so the number has to come off the panel in your hand.

The form comparison, run in the population the stack is sold to. In women genotyped for the 677C>T polymorphism, [6S]-5-methyltetrahydrofolate raised plasma folate more effectively than an equivalent dose of folic acid Prinz-Langenohl 2009. Note what that trial measured: plasma folate, a pharmacokinetic endpoint. It is the right evidence for the claim that the active form gets in better. It is not evidence that the active form prevents anything, and nobody has run the outcome version.

The obstacle, stated as a number rather than a caveat. Homocysteine has a floor. Below roughly 8-9 micromol/L there is very little left to remove and the response to any of these ingredients flattens. The trials that produced clean falls enrolled people who were elevated to begin with. If your baseline draw comes back at 7, this bundle has almost no room to work in, and the honest prediction for that reader is a flat retest.

Methylation Stack — which form, and does it matter

Folate. Folic acid is a synthetic oxidized form that has to be reduced by dihydrofolate reductase before it enters the cycle, and human DHFR activity for that substrate is low and variable, which is how unmetabolized folic acid ends up circulating after large doses. [6S]-5-methyltetrahydrofolate skips the reduction and skips MTHFR entirely Prinz-Langenohl 2009. Two details on the label decide whether you have it: the [6S] or L- prefix, because the [6R] diastereomer is biologically inert and a racemic product is half filler; and the salt, calcium versus glucosamine, which changes stability rather than activity.

B12. Methylcobalamin is the form methionine synthase actually holds, which is the marketing argument, and it is true as far as it goes. What it leaves out is that the cell interconverts cobalamin forms anyway, and that the second active form, adenosylcobalamin, is what methylmalonyl-CoA mutase needs — a methyl-only product supports one of the two B12-dependent enzymes in human biochemistry. Hydroxocobalamin covers both and holds longer. Cyanocobalamin is the cheap one, is what most of the trial literature used, and releases a trivial cyanide moiety that matters only in renal failure and in Leber's hereditary optic neuropathy, where it is genuinely contraindicated.

B6. Pyridoxine hydrochloride has to be phosphorylated by pyridoxal kinase to become PLP, the form CBS and CTH use. Pyridoxal-5-phosphate is sold as the shortcut. The form question here is not mainly about efficacy — it is about safety, and it runs the opposite way to the marketing. The sensory neuropathy this vitamin is known for is a pyridoxine phenomenon at high chronic intake, so a stack that uses the cheap form is the one where the total daily milligrams matter most.

Betaine. Betaine anhydrous and betaine hydrochloride are not interchangeable and the confusion is common enough to be worth a sentence. Anhydrous TMG is the methyl donor in Steenge 2003. Betaine HCl is sold as a stomach-acid aid, is dosed in the hundreds of milligrams, and delivers a fraction of the betaine per capsule. A bundle listing betaine HCl has not put the homocysteine trial in the box.

What would have to be true, and how you would know it was not

Four predictions with numbers, windows and one that argues against buying this.

1. Homocysteine falls, and how far depends on where it started. Draw it fasting before the first capsule and again at 12 weeks, from the same lab. If baseline is above 12 micromol/L, expect a fall of roughly a quarter on the folate and B12 arms alone Clarke 2010. If baseline is under 9, expect almost nothing, and that is the mechanism behaving correctly rather than the product failing.

2. RBC folate rises, but not on the schedule people retest on. Red cells take up folate only while they are being made, and they live about 120 days, so RBC folate is a rolling four-month average. Retesting at 4 weeks measures mostly the old population and will understate the change. 16 weeks is the first honest retest. Serum folate moves in days and tells you what you ate this week.

3. Methylmalonic acid is the B12 test to run, not serum B12. Serum B12 counts bound and unbound cobalamin and can sit in the normal range in someone who is functionally deficient. MMA is the substrate that accumulates when the adenosylcobalamin-dependent enzyme is starved, so it moves when B12 status actually changes. Predict MMA falls if it was raised and stays flat if it was not.

4. The prediction that cuts against this bundle: ApoB will not move, and neither will hs-CRP. Homocysteine was adopted as a cardiovascular marker on observational grounds, and the randomized test of that idea — 8 trials, 37,485 people — lowered the marker and left events unchanged Clarke 2010. So run ApoB and hs-CRP alongside, expect both to be flat at 12 weeks, and treat a falling homocysteine beside an unchanged ApoB as what this stack honestly is: a correction of a biochemical number whose clinical value is unproven. Anyone taking this for their heart should know that before the first draw rather than after the fifth bottle.

What nobody has tested yet

The trial that would justify the word bundle, and its exact design. Four arms, adults screened to a fasting homocysteine above 12 micromol/L, roughly 60 per arm: the full stack; 5-MTHF plus methylcobalamin only; betaine 6 g/day only; placebo. Primary endpoint fasting homocysteine at 12 weeks, with a pre-specified test for interaction. Additivity says the full arm falls by about the sum of arms two and three. Synergy says it falls further, which the shared methionine-synthase step gives a reason to expect. Adherence says all three active arms land together and the only thing the bundle bought was one bottle instead of three. Nobody has run it for this product or for any competing one, and the reagents are three commodity ingredients and a homocysteine assay.

Nobody has tested 5-MTHF against folic acid on an outcome. The comparison exists for plasma folate Prinz-Langenohl 2009. It does not exist for homocysteine normalization rates, for pregnancy outcomes, or for anything a person would care about, and the entire commercial premium of the methylated category rests on the assumption that the pharmacokinetic advantage carries through. It might. It has never been shown.

Nobody has stratified a methylation trial by MTHFR genotype prospectively. The stack is marketed to C677T carriers Frosst 1995, and the sensible experiment — genotype first, randomize within genotype, report the TT and CC arms separately — would say whether the genotype predicts response at all. Reading it out of subgroups afterwards is not the same test and is how this field has been arguing for two decades.

And nobody has measured the thing sensitive people actually report. The most common complaint about methyl donors is agitation, insomnia or irritability in the first week, always described as overmethylation and never measured. A crossover with a validated anxiety scale and actigraphy, 30 people, two weeks per arm, would turn a forum anecdote into a rate. It has not been done.

Methylation Stack — its own safety story, not its category's

The folate-masking rule, stated mechanistically because the slogan version gets ignored. B12 deficiency produces two separate injuries: a megaloblastic anemia, which folate corrects because both vitamins feed thymidylate synthesis, and a demyelinating myelopathy, which folate does nothing about. Give folate alone and the blood count normalizes while subacute combined degeneration of the cord continues silently. This bundle contains B12, which mostly closes the hole — but if you are taking it beside a separate high-dose folate, or you are vegan, over 60, on metformin or on a proton pump inhibitor, measure MMA before you start, not serum B12.

The B6 total, which is the one number nobody adds up. Chronic high-dose pyridoxine causes a dose- and duration-dependent sensory neuropathy — numbness and ataxia that resolve slowly and sometimes incompletely. The US tolerable upper intake level is 100 mg/day. A methylation bundle, a B-complex, a magnesium product with added B6 and two energy drinks can pass that without any single label looking unreasonable, and the neuropathy has been reported below the UL when the exposure ran for years. Add the milligrams across every product on your shelf.

Three drug interactions that belong specifically to this box. Methotrexate works by inhibiting dihydrofolate reductase, so folate supplementation is deliberate and dose-timed in rheumatology and is a different calculation in oncology — never start a methylation stack on methotrexate without telling the prescriber. Folate lowers plasma phenytoin and can reduce seizure control. And nitrous oxide irreversibly oxidizes the cobalt in methylcobalamin, inactivating methionine synthase; in someone with marginal B12 status, a single anesthetic or recreational exposure has precipitated myeloneuropathy, and a bundle containing B12 is protective here rather than harmful, which is worth knowing in the right direction.

What this stack cannot do, and the substitution risk. A raised homocysteine has causes other than diet: renal impairment, hypothyroidism, and the drugs above. Treating the number with capsules without asking why it is raised is the way a kidney or thyroid problem gets a year to develop. And an elevated homocysteine with a normal ApoB is not a cardiovascular emergency; an elevated ApoB with a normal homocysteine is the one that needs attention.

Sources read for this page

• Frosst P, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genetics, 1995 · PMID 7647779
• Steenge GR, et al. Betaine supplementation lowers plasma homocysteine in healthy men and women. The Journal of Nutrition, 2003 · PMID 12730412
• Prinz-Langenohl R, et al. [6S]-5-methyltetrahydrofolate increases plasma folate more effectively than folic acid in women with the homozygous or wild-type 677C-->T polymorphism of methylenetetrahydrofolate reductase. British Journal of Pharmacology, 2009 · PMID 19917061
• Clarke R, et al. Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals. Archives of Internal Medicine, 2010 · PMID 20937919

How you would know if it worked

Methylation Stack — safety & side effects

Bloodwork to run alongside Methylation Stack

Baseline first, then again at 8–12 weeks.

The Basics — Start Here panel covers these in one order — 4 markers, $32.40 with the discount applied.

Check results you already have → · All 103 markers A–Z

Methylation Stack — frequently asked questions

What Methylation Stack is used for

Methylation Stack appears under 2 goals in the goal router.

Related Stacks & Bundles supplements

← Browse the full Supplement Vault

↑ Back to on this page